Amundi Sells 256,917 Shares of HCA Healthcare, Inc. $HCA

Amundi reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 41.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 358,177 shares of the company's stock after selling 256,917 shares during the quarter. Amundi owned 0.17% of HCA Healthcare worth $139,650,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. California State Teachers Retirement System raised its holdings in shares of HCA Healthcare by 38,348.7% in the second quarter. California State Teachers Retirement System now owns 89,141,330 shares of the company's stock valued at $34,755,313,000 after buying an additional 88,909,485 shares during the last quarter. BlackRock Inc. bought a new position in shares of HCA Healthcare in the 2nd quarter valued at about $5,069,974,000. Norges Bank acquired a new position in HCA Healthcare in the fourth quarter valued at approximately $1,262,513,000. Legal & General Group Plc bought a new stake in HCA Healthcare in the second quarter valued at about $410,992,000. Finally, Jupiter Topco LLC bought a new stake in shares of HCA Healthcare in the 2nd quarter valued at about $371,138,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

HCA stock opened at $401.80 on Wednesday. The stock has a market cap of $86.99 billion, a price-to-earnings ratio of 13.45, a price-to-earnings-growth ratio of 1.33 and a beta of 1.10. The company has a fifty day moving average price of $403.82 and a two-hundred day moving average price of $434.97. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same quarter in the prior year, the business earned $6.84 EPS. HCA Healthcare's quarterly revenue was up 8.7% on a year-over-year basis. Research analysts anticipate that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare's dividend payout ratio (DPR) is presently 10.45%.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Oppenheimer lowered their target price on shares of HCA Healthcare from $520.00 to $485.00 and set an "outperform" rating for the company in a research note on Monday, July 27th. UBS Group dropped their price objective on shares of HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a report on Monday, July 27th. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $435.00 target price on shares of HCA Healthcare in a research note on Tuesday. Cantor Fitzgerald decreased their price objective on HCA Healthcare from $588.00 to $525.00 and set an "overweight" rating for the company in a report on Tuesday, July 7th. Finally, Deutsche Bank Aktiengesellschaft set a $476.00 price objective on shares of HCA Healthcare in a research report on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $462.64.

About HCA Healthcare

HCA Healthcare, Inc NYSE: HCA is a healthcare services company that operates hospitals and other healthcare facilities. Its network provides a broad range of medical services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic services, and maternity care.

The company also operates ambulatory surgery centers, urgent care facilities, physician practices, and other outpatient locations. HCA Healthcare serves patients through facilities located across the United States, as well as through HCA Healthcare UK, its healthcare operations in the United Kingdom.

HCA Healthcare was founded in 1968 by Dr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.